Abstract
To determine the potential for differential release of islet amyloid polypeptide and insulin, we performed studies in rat islet monolayer cultures under conditions known to impair regulated beta-cell secretion. In inhibiting concentrations of epinephrine or the absence of calcium, islet amyloid polypeptide was secreted through a constitutive pathway while insulin was not. These findings suggest a mechanism for persistent islet amyloid polypeptide secretion and amyloid accumulation when regulated insulin release is impaired as in Type 2 (non-insulin-dependent) diabetes mellitus and insulinomas. © 1993 Springer-Verlag.
Author supplied keywords
Cite
CITATION STYLE
Kahn, S. E., Verchere, C. B., D’Alessio, D. A., Cook, D. L., & Fujimoto, W. Y. (1993). Evidence for selective release of rodent islet amyloid polypeptide through the constitutive secretory pathway. Diabetologia, 36(6), 570–573. https://doi.org/10.1007/BF02743276
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.